益生菌补充预防机械通气ICU患者呼吸机相关性肺炎：随机对照试验系统综述与网络Meta分析数据表1.PDF

数据集获取（Figshare）

• 源站标题：Data_Sheet_1_Probiotic Supplementation Prevents the Development of Ventilator-Associated Pneumonia for Mechanically Ventilated ICU Patients: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.PDF
• DOI：10.3389/fnut.2022.919156.s001
• 发布日期：2022-07-08
• 文件数：1 个
• 文件总体积：45.14 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Probiotic_Supplementation_Prevents_the_Development_of_Ventilator-Associated_Pneumonia_for_Mechanically_Ventilated_ICU_Patients_A_Systematic_Review_and_Network_Meta-analysis_of_Randomized_Controlled_Trials_PDF/20268216

命令行下载

curl -L -o "Data_Sheet_1_Probiotic Supplementation Prevents the Development of Ventilator-Associated Pneumonia for Mechanically Ventilated ICU Patients: A Systema.PDF" "https://ndownloader.figshare.com/files/36205170"

文件清单

• Data_Sheet_1_Probiotic Supplementation Prevents the Development of Ventilator-Associated Pneumonia for Mechanically Ventilated ICU Patients: A Systema.PDF（45.14 KB）

文件总体积 45.14 KB（源站 API 实测）。

数据说明

BackgroundVentilator-associated pneumonia (VAP) is one of the common critical complications of nosocomial infection (NI) in invasive mechanically ventilated intensive care unit (ICU) patients. The efficacy of total parenteral nutrition (TPN), enteral nutrition and/or adjuvant peripheral parenteral nutrition (EPN) supplemented with or without probiotic, prebiotic, and synbiotic therapies in preventing VAP among these patients has been questioned. We aimed to systematically and comprehensively summarize all available studies to generate the best evidence of VAP prevention for invasive mechanically ventilated ICU patients.
MethodsRandomized controlled trials (RCTs) for the administration of TPN, EPN, probiotics-supplemented EPN, prebiotics-supplemented EPN, and synbiotics-supplemented EPN for VAP prevention in invasive mechanically ventilated ICU patients were systematically retrieved from four electronic databases. The incidence of VAP was the primary outcome and was determined by the random-effects model of a Bayesian framework. The secondary outcomes were NI, ICU and hospital mortality, ICU and hospital length of stay, and mechanical ventilation duration. The registration number of Prospero is CRD42020195773.
ResultsA total of 8339 patients from 31 RCTs were finally included in network meta-analysis. The primary outcome showed that probiotic-supplemented EPN had a higher correlation with the alleviation of VAP than EPN in critically invasive mechanically ventilated patients (odds ratio [OR] 0.75; 95% credible intervals [CrI] 0.58–0.95). Subgroup analyses showed that probiotic-supplemented EPN prevented VAP in trauma patients (OR 0.30; 95% CrI 0.13–0.83), mixed probiotic strain therapy was more effective in preventing VAP than EPN therapy (OR 0.55; 95% CrI 0.31–0.97), and low-dose probiotic therapy (less than 1010 CFU per day) was more associated with lowered incidence of VAP than EPN therapy (OR 0.16; 95% CrI 0.04–0.64). Secondary outcomes indicated that synbiotic-supplemented EPN therapy was more significantly related to decreased incidence of NI than EPN therapy (OR 0.34; 95% CrI 0.11–0.85). Prebiotic-supplemented EPN administration was the most effective in p

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fnut.2022.919156.s001（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Probiotic_Supplementation_Prevents_the_Development_of_Ventilator-Associated_Pneumonia_for_Mechanically_Ventilated_ICU_Patients_A_Systematic_Review_and_Network_Meta-analysis_of_Randomized_Controlled_Trials_PDF/20268216）。